Cyclo Therapeutics, Inc. Warrant
CYTHW
CYTHW was delisted on the 25th of March, 2025.
2 hedge funds and large institutions have $2.66K invested in Cyclo Therapeutics, Inc. Warrant in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
19% less capital invested
Capital invested by funds: $3.29K → $2.66K (-$634)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$24 |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$6 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $2.64K | +$6 | +20 | +0.2% |
|
|
2
UBS Group
Zurich,
Switzerland
| $19 | +$24 | +81 | New |
|
CYTHW Hedge Fund Activity: Q1 2024 in Review
2 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Cyclo Therapeutics, Inc. Warrant (CYTHW) for Q1 2024, worth a combined $2.66K — down 19% from $3.29K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new CYTHW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $24.
- 2 institutional investors held Cyclo Therapeutics, Inc. Warrant (CYTHW) as of Q1 2024, up from 1 in Q4 2023.
- Funds reported $2.66K of Cyclo Therapeutics, Inc. Warrant stock for Q1 2024, down 19% quarter-over-quarter.
- 1 fund opened new Cyclo Therapeutics, Inc. Warrant positions in Q1 2024 and 0 closed out, a net change of +1 holder.
- The largest Cyclo Therapeutics, Inc. Warrant buyer in Q1 2024 was UBS Group, an estimated $24 added.
Based on aggregated 13F filings for Q1 2024.